A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

Explore our latest breakthroughs in RNA Interference Research. Learn more about our innovative pipeline today! @ RNA ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

Editas Medicine, Inc. ( NASDAQ: EDIT) Strategic Update Conference Call October 22, 2024 8:00 AM ET ...

Akamis Bio, a clinical-stage oncology company using a proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn®) platform to ...

Colossal, the company founded to try to restore the mammoth to the Arctic tundra, has also decided to tackle a number of ...

The Cambridge-GSK Translational Immunology Collaboration builds on an existing scientific relationship between the biopharma company and the university, with the aim of improving outcomes for patients ...

The researchers analyzed CD4 T cell and B cell responses 7 days and 3–6 months after two doses of the SARS-CoV-2 messenger ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

The New York Times crossword puzzle can be tough! If you're stuck, we're here to help with a list of today's clues and ...

Passed Up for the Ticket, Shapiro Tries to Deliver Pennsylvania for Harris Gov. Josh Shapiro of Pennsylvania may not be on the verge of the vice presidency, but he says he has everything riding on ...

We’ve spent two years examining the implications of a second Donald Trump presidency. He wants to radically reshape the federal government and consolidate executive power. He tried to do much of ...